Astera Labs (NASDAQ:ALAB) Director Manuel Alba Sells 183,000 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director owned 253,863 shares in the company, valued at $71,114,642.19. This represents a 41.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Manuel Alba also recently made the following trade(s):

• On Wednesday, July 1st, Manuel Alba sold 136,974 shares of Astera Labs stock. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74.
• On Wednesday, July 1st, Manuel Alba sold 37,535 shares of Astera Labs stock. The stock was sold at an average price of $447.39, for a total value of $16,792,783.65.
• On Wednesday, July 1st, Manuel Alba sold 8,491 shares of Astera Labs stock. The stock was sold at an average price of $458.38, for a total value of $3,892,104.58.

Astera Labs Trading Up 3.2%

NASDAQ ALAB traded up $8.69 during trading on Thursday, reaching $282.82. 2,785,831 shares of the company’s stock were exchanged, compared to its average volume of 5,307,284. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The company’s fifty day simple moving average is $334.67 and its 200-day simple moving average is $252.89. The firm has a market capitalization of $49.07 billion, a PE ratio of 140.01 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Institutional Trading of Astera Labs

Institutional investors have recently added to or reduced their stakes in the business. Royal Bank of Canada boosted its position in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC raised its position in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after purchasing an additional 7,756 shares during the period. Empowered Funds LLC lifted its stake in shares of Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares during the last quarter. First Trust Advisors LP boosted its holdings in shares of Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after buying an additional 56,952 shares during the period. Finally, Brown Advisory Inc. boosted its holdings in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after buying an additional 1,977 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have issued reports on ALAB. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a report on Monday, August 17th. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Susquehanna increased their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Finally, Roth Capital reissued a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $348.33.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.